Veradermics, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2019-10-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.veradermics.com
Clinical Trials
5
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (5 trials with phase data)โข Click on a phase to view related trials
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
- Conditions
- Androgenetic Alopecia (AGA)Androgenetic AlopeciaAGAFemale Androgenetic AlopeciaHair Loss
- Interventions
- Drug: VDPHL01 BIDDrug: VDPHL01 QDDrug: Placebo
- First Posted Date
- 2025-08-28
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 552
- Registration Number
- NCT07146022
- Locations
- ๐บ๐ธ
Site 73, Birmingham, Alabama, United States
๐บ๐ธSite 89, Birmingham, Alabama, United States
๐บ๐ธSite 77, Phoenix, Arizona, United States
Safety and Efficacy of VDPHL01 in Males With AGA
- Conditions
- Androgenetic AlopeciaAGAMale Pattern Baldness
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-05-14
- Last Posted Date
- 2025-07-14
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06972264
- Locations
- ๐บ๐ธ
Site 89, Birmingham, Alabama, United States
๐บ๐ธSite 77, Phoenix, Arizona, United States
๐บ๐ธSite 93, Northridge, California, United States
Efficacy and Safety of VDPHL01 in Males With AGA
- Conditions
- Androgenetic AlopeciaAGAMale Pattern Baldness
- Interventions
- Drug: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 480
- Registration Number
- NCT06724614
- Locations
- ๐บ๐ธ
Site 36, Birmingham, Alabama, United States
๐บ๐ธSite 28, Phoenix, Arizona, United States
๐บ๐ธSite 30, Fort Smith, Arkansas, United States
Safety and Efficacy of VDPHL01 in Males and Females With AGA
- Conditions
- Androgenetic AlopeciaAGAMale Pattern Baldness
- Interventions
- First Posted Date
- 2024-07-30
- Last Posted Date
- 2025-09-03
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 70
- Registration Number
- NCT06527365
- Locations
- ๐บ๐ธ
01, San Diego, California, United States
๐บ๐ธ04, New Albany, Indiana, United States
๐บ๐ธ03, Hackensack, New Jersey, United States
Safety and Efficacy of VDMN-21 Patch in Subjects With Common Warts
- Conditions
- Common WartVerruca VulgarisWarts
- Interventions
- Drug: VDMN-21 Patch Low DoseDrug: VDMN-21 Patch High DoseDrug: Vehicle Patch
- First Posted Date
- 2023-04-05
- Last Posted Date
- 2025-05-08
- Lead Sponsor
- Veradermics, Inc.
- Target Recruit Count
- 153
- Registration Number
- NCT05799157
- Locations
- ๐บ๐ธ
Site 07, Fort Smith, Arkansas, United States
๐บ๐ธSite 16, San Diego, California, United States
๐บ๐ธSite 02, Plainfield, Indiana, United States